Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis And Forecast To 2031: By Product (Instruments, Reagents), By Technology (Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis And Forecast To 2031: By Product (Instruments, Reagents), By Technology (Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Helicase-dependent Amplification (HDA)), By Application, (Infectious Disease, Oncology, Blood Screening), By End-use (Hospitals, Diagnostic Laboratories) And Region

The global Isothermal Nucleic Acid Amplification Technology (INAAT) Market was valued at USD 1.4 billion in 2021 and it is anticipated to grow up to USD 3.1 billion by 2031, at a CAGR of 8.4% during the forecast period.

Isothermal nucleic acid amplification technology (INAAT) methods allow for the rapid, exponential detection of a nucleic acid target sequence. This process is not limited by the constraint of thermal cycling. Isothermal amplification, when integrated into microsystems or portable devices, improves nucleic acid-based on-site diagnostics and increases sensitivity. In addition, using different enzymatic approaches to separate the two DNA strands prior to replication, INAAT can achieve amplification in 15-16 minutes.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Scope and Report Structure

[table

Market Trends and Drivers

The rising prevalence of infectious diseases around the world is expected to fuel market growth significantly over the forecast period. The rising prevalence of infectious diseases such as influenza, HIV, and tuberculosis has increased the demand for better diagnostic and treatment procedures in healthcare institutions. According to the WHO report 2021, 1.5 million people died from tuberculosis in 2020. Tuberculosis is the world's 13th leading cause of death and the second leading infectious killer, after only COVID-19 (but above of HIV/AIDS). Furthermore, nearly 10 million people worldwide were infected with tuberculosis in 2020. There were 5.6 million males, 3.3 million women, and 1.1 million children. Tuberculosis affects people of all ages and in all countries.

PCR is the standard method for diagnosing such disorders. However, with developments in INAAT, the diagnosis can be accomplished rapidly and affordably. As a result, the demand for diagnostics for these disorders has increased, as has the need for INAAT solutions. As a result, the rising prevalence of chronic diseases has increased demand for INAAT diagnostic services, propelling overall isothermal nucleic acid amplification technology market growth.

Market Restraints and Challenges

Lack of awareness about this technology may hamper the industry growth to some extent. Another key restraint in the INAAT market is the high cost of this technology. INAAT is a very expensive technology and this makes it unaffordable for many people. This high cost is a major barrier to the widespread adoption of this technology. The main challenge in the INAAT market is to make this technology more affordable so that it can be adopted by a larger number of people. This challenge can be addressed by increasing awareness about this technology and by reducing its cost of this technology.

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmental Overview

The report analyses the global Isothermal Nucleic Acid Amplification Technology (INAAT) Market based on product, technology, application, end-user, and region.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Product

Based on the product, the isothermal nucleic acid amplification technology (INAAT) industry is bifurcated into instruments, and reagents. Of these, the reagent segment registered significant revenue in 2021. The growing availability of diagnostic tests for infectious diseases has created new growth opportunities. Access to varied reagents, greater approvals of CLIA-waived tests, the constant launch of faster, newer, and more reliable POC solutions, and rising infectious disease prevalence are all major factors propelling growth avenues in the next years. Similarly, the increasing usage of regents in assay development, fundamental research, and treatments, as well as frequent reagent purchases, will increase growth prospects in the approaching years.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Technology

By technology, the industry is divided into Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), and Helicase-dependent Amplification (HDA). In 2021, the loop-mediated isothermal amplification (LAMP) segment was expected to account for the largest market share in 2021. The loop-mediated isothermal amplification (LAMP) test is the most extensively used method for amplifying DNA and RNA and identifying genetically engineered organisms. Furthermore, as compared to PCR technology, this technique provides significant competitive advantages. The LAMP test is PCR inhibitor resistant, making it appropriate for direct sample analysis. Furthermore, because the test is performed at a constant temperature, a thermocycler is not required.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application

Based on application, the industry is categorized into infectious disease, oncology, blood screening and others. Infectious disease is further divided into HIV, influenza, malaria, and tuberculosis. The blood screening segment is expected to grow at a highest CAGR between 2022 and 2031. According to the specific tests, blood screening tests help to understand overall blood health, metabolism, liver function, mineral levels, and a variety of other biomarkers. Blood tests are performed to screen for diseases such as cancer and infections. In blood screening, several methods such as next generation sequencing, western blot assay, enzyme-linked immunosorbent assay, nucleic acid test, and others are employed. People choose blood screening because it provides full information about their current health status. It can detect potential health problems in their early stages, when they can be most successfully managed. Furthermore, several blood screening kits for diagnosis are being released by corporations.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by End-user

Based on end-use, the isothermal nucleic acid amplification technology (INAAT) market is divided into hospitals, diagnostic laboratories, and others. The hospital segment accounted for over USD 628 million in 2021. Hospitals are well equipped with fully automated INAAT instruments that offer quick test results as compared to laboratories. Besides this, the most complex and sensitive diagnostic procedures are performed in hospitals by the skilled staff to minimize the chances of error. Furthermore, with rapid growing healthcare industry, the number of hospitals has also increased thereby fueling its isothermal nucleic acid amplification technology market growth. Owing to these factors, the demand for INAAT test in hospitals is higher than the other end-use segments.

Geographical Analysis of Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America isothermal nucleic acid amplification technology (INAAT) market captured significant market share in 2021 and is poised to grow substantially during the forthcoming years. Advances in isothermal nucleic acid amplification technology (INAAT) and an increasing preference in the region for INAAT testing over traditional diagnostic techniques are ascribed to regional growth. The rising prevalence of chronic diseases in the region will also have a beneficial impact on market growth. According to the Centers for Disease Control and Prevention (CDC), in the United States in 2018, there were 1,708,921 new cancer cases reported and 599,265 cancer deaths. There were 436 new cancer cases reported for every 100,000 individuals, and 149 people died from cancer. Furthermore, the rising number of new product launches, as well as the strong penetration of key industry rivals in North America, are propelling the market forward.

Major Players in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

The key players in the market

COVID-19 Impact

COVID-19 pandemic positively impacted isothermal nucleic acid amplification technology (INAAT) market. Since INAAT offers simple operation, rapid detection, and accurate results. As a result, it becomes more ideal for primary testing centers in urban as well as rural areas. INAAT is in high demand since PCR-based nucleic acid detection technology is time-consuming and requires specialist equipment. Moreover, it is difficult to work with PCR in primary-level medical institutions. Antibody-based detection has limitations because of the late appearance of antibodies, that makes early diagnosis of virus difficult, whereas antigen-based detection has low sensitivity, that often result a high false-negative rate.

Recent Developments

• In May 2022, Meridian Bioscience, Inc. launched the new Lyo-Ready Direct RNA/DNA LAMP and Lyo-Ready Direct DNA LAMP Saliva Mix master mixes for isothermal applications.
• In March 2022, Thermo Fisher Scientific has launched two new reverse transcription loop-mediated isothermal amplification (RT-LAMP)-based solutions. This isothermal RT-LAMP nucleic-acid-based amplification provides a rapid and low-cost option for viral pathogen detection. Such product launches will help company in widening its product portfolio, thereby propelling its market growth.
• In March 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test runs on the company's ID NOW platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments. This launch has helped to improve the company’s product portfolio and escalate its market position.

Frequently Asked Questions

Q1. How big is the Isothermal Nucleic Acid Amplification Technology (INAAT) Market?Ans. The global Isothermal Nucleic Acid Amplification Technology (INAAT) Market size was USD 1.4 billion in 2021 and is anticipated to reach USD 3.1 billion in 2031, growing at a rate of 8.4% from 2022 to 2031.Q2. What is the Isothermal Nucleic Acid Amplification Technology (INAAT) Market growth rate?Ans. The growth rate of the Isothermal Nucleic Acid Amplification Technology (INAAT) Market is 8.4%.Q3. Which region holds a major market share for the market?Ans. North America holds a major market share of the Isothermal Nucleic Acid Amplification Technology (INAAT) Market in 2021.Q4. Which segment accounted for the largest Isothermal Nucleic Acid Amplification Technology (INAAT) Market share?Ans. By end-user, the research laboratories segment accounted for the largest Isothermal Nucleic Acid Amplification Technology (INAAT) Market share.Q5. Who are the key players in the Isothermal Nucleic Acid Amplification Technology (INAAT) Market?Ans. The global Isothermal Nucleic Acid Amplification Technology (INAAT) Market report includes players such as Q6. What are the factors driving the Isothermal Nucleic Acid Amplification Technology (INAAT) Market growth?Ans. The major factors driving the growth of the market are rising prevalence of infectious diseases coupled with increasing adoption of INAAT over PCR.Q7. What are the key growth strategies of Isothermal Nucleic Acid Amplification Technology (INAAT) Market players?Ans. The key growth strategies of Isothermal Nucleic Acid Amplification Technology (INAAT) Market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Isothermal Nucleic Acid Amplification Technology (INAAT) Market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Isothermal Nucleic Acid Amplification Technology (INAAT) Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.